News

The outbreak of COVID-19 has substantially disrupted the management of civil litigation during the first national lockdown of 17 March 2020 to 11 May 2020. French judicial activity was limited to "essential litigation" and business continuity plans were implemented by the French courts.

In an effort to control the spread of COVID-19, the Mexican federal government implemented a “traffic light” monitoring system in June 2020 to alert residents to the epidemiological risks in each of the country’s 32 states and provide guidance on restrictions on certain activities.

Many employees take advantage of the opportunity to save taxes by placing funds in their employer’s health or dependent care flexible spending arrangements (FSAs). As the end of 2020 nears, here are some rules and reminders to keep in mind....

California is making significant progress on a first-of-its-kind regulation that will reduce GHG emissions from ride-sharing vehicles.

In a recent decision granting institution of an inter partes review (IPR), the Patent Trial and Appeal Board reconfirmed that it will not deny an IPR petition just because the parties previously agreed to resolve their disputes in a different forum.

As a part of last year’s changes to the Illinois Human Rights Act (read more here), all Illinois employers are required to provide sexual harassment training for all employees and management personnel on an annual basis, with the first compliance period ending December 31, 2020.  Notably, the Ill

Over the past two weeks, there have been a number of announced clinical studies and updates from biosimilar developers around the world. On November 9, Shanghai based Henlius Biotech, Inc.

In a year dominated by the pandemic, it is easy to lose sight of some of the more granular legal developments and trends coming over the horizon for 2021 which, in their own ways, can also have a significant impact on the UK/EU private equity & investment community as well as the underlying b

It has long been understood that claim construction can, and frequently is, dispositive in patent litigation.  This truism was the basis for the Federal Circuit affirming the District Court's decision against a generic drug producer in its recent decision in Par Pharmaceutical, Inc. v.

Pages